Wheeze and Intermittent Treatment

Summary

Wheeze and Intermittent Treatment is a clinical trial^[1].

Key Facts

• Wheeze and Intermittent Treatment is in the country of United Kingdom^[2].
• Wheeze and Intermittent Treatment's instance of is recorded as clinical trial^[3].
• Wheeze and Intermittent Treatment's start time is recorded as +2010-11-30T00:00:00Z^[4].
• Wheeze and Intermittent Treatment's end time is recorded as +2014-02-28T00:00:00Z^[5].
• Wheeze and Intermittent Treatment's sponsor is recorded as Queen Mary University of London^[6].
• Wheeze and Intermittent Treatment's number of participants is recorded as {'unit': '1', 'amount': '+1358'}^[7].
• Wheeze and Intermittent Treatment's title is recorded as Parent-determined Oral Montelukast Therapy for Preschool Wheeze With Stratification for Arachidonate-5-Lipoxygenase (ALOX5) Promoter Genotype^[8].
• Wheeze and Intermittent Treatment's short name is recorded as WAIT^[9].
• Wheeze and Intermittent Treatment's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q5151', 'amount': '+10'}^[10].
• Wheeze and Intermittent Treatment's ClinicalTrials.gov ID is recorded as NCT01142505^[11].
• Wheeze and Intermittent Treatment's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+5'}^[12].
• Wheeze and Intermittent Treatment's research intervention is recorded as montelukast^[13].
• Wheeze and Intermittent Treatment's research intervention is recorded as D-(-)-mannitol^[14].
• Wheeze and Intermittent Treatment's clinical trial phase is recorded as phase III clinical trial^[15].
• Wheeze and Intermittent Treatment's research site is recorded as Barts Health NHS Trust^[16].
• Wheeze and Intermittent Treatment's study type is recorded as interventional study^[17].